Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Robust dynamical invariants in sequential neural activity.

Elices I, Levi R, Arroyo D, Rodriguez FB, Varona P.

Sci Rep. 2019 Jun 21;9(1):9048. doi: 10.1038/s41598-019-44953-2.

2.

An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients.

Bermudez-Lopez M, Forne C, Amigo N, Bozic M, Arroyo D, Bretones T, Alonso N, Cambray S, Del Pino MD, Mauricio D, Gorriz JL, Fernandez E, Valdivielso JM.

Expert Opin Ther Targets. 2019 Jul;23(7):619-630. doi: 10.1080/14728222.2019.1620206. Epub 2019 May 23.

PMID:
31100024
3.

Efficacy of the SEPARPROCATH® radiation drape to reduce radiation exposure during cardiac catheterization: A pilot comparative study.

Patet C, Ryckx N, Arroyo D, Cook S, Goy JJ.

Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28130. [Epub ahead of print]

PMID:
30773797
4.

Handheld ECG Tracking of in-hOspital Atrial Fibrillation The HECTO-AF trial Clinical Study Protocol.

Schukraft S, Mancinetti M, Hayoz D, Faucherre Y, Cook S, Arroyo D, Puricel S.

Trials. 2019 Jan 30;20(1):92. doi: 10.1186/s13063-019-3189-7.

5.

Effects of rapamycin in combination with fludarabine on primary chronic lymphocytic leukemia cells.

Rodriguez CM, Bussi C, Arroyo DS, Sastre D, Heller V, Stanganelli C, Slavutsky I, Iribarren P.

Leuk Lymphoma. 2019 May;60(5):1299-1303. doi: 10.1080/10428194.2018.1529309. Epub 2018 Nov 8. No abstract available.

PMID:
30407097
6.

Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells.

Bussi C, Peralta Ramos JM, Arroyo DS, Gallea JI, Ronchi P, Kolovou A, Wang JM, Florey O, Celej MS, Schwab Y, Ktistakis NT, Iribarren P.

J Cell Sci. 2018 Nov 30;131(23). pii: jcs226241. doi: 10.1242/jcs.226241.

7.

Compulsory community treatment and ethnicity: Findings from a culturally and linguistically diverse area of Queensland.

Moss K, Wyder M, Braddock V, Arroyo D, Kisely S.

Int J Law Psychiatry. 2019 Jan - Feb;62:154-159. doi: 10.1016/j.ijlp.2018.09.007. Epub 2018 Sep 28.

PMID:
30274852
8.

Acute hemolytic pancreatitis and hepatitis secondary to percutaneous pharmacomechanical thrombectomy of prosthetic vascular access for hemodialysis.

Urdaneta J, Arroyo D, Mon C, Abadal J, Gálvez E, Ortiz M, Camacho R, Herrero JC.

Nefrologia. 2019 Jan - Feb;39(1):104-105. doi: 10.1016/j.nefro.2018.06.005. Epub 2018 Aug 14. English, Spanish. No abstract available.

9.

Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).

Goicoechea M, de Vinuesa SG, Quiroga B, Verde E, Bernis C, Morales E, Fernández-Juárez G, de Sequera P, Verdalles U, Delgado R, Torres A, Arroyo D, Abad S, Ortiz A, Luño J.

Cardiovasc Drugs Ther. 2018 Jun;32(3):255-263. doi: 10.1007/s10557-018-6802-1.

PMID:
29943364
10.

Correction to: Impact of intravascular thrombosis on failure of radial arterial catheters in critically ill patients: a nested case-control study.

Fleury Y, Arroyo D, Couchepin C, Robert-Ebadi H, Righini M, Lobrinus JA, Ricou B, Delieuvin Schmitt N, Gayet-Ageron A.

Intensive Care Med. 2018 May;44(5):699-700. doi: 10.1007/s00134-018-5185-x.

PMID:
29846747
11.

Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.

Ayasreh N, Bullich G, Miquel R, Furlano M, Ruiz P, Lorente L, Valero O, García-González MA, Arhda N, Garin I, Martínez V, Pérez-Gómez V, Fulladosa X, Arroyo D, Martínez-Vea A, Espinosa M, Ballarín J, Ars E, Torra R.

Am J Kidney Dis. 2018 Sep;72(3):411-418. doi: 10.1053/j.ajkd.2018.03.019. Epub 2018 May 18.

PMID:
29784615
12.

Phosphatidyl-Inositol-3 Kinase Inhibitors Regulate Peptidoglycan-Induced Myeloid Leukocyte Recruitment, Inflammation, and Neurotoxicity in Mouse Brain.

Arroyo DS, Gaviglio EA, Peralta Ramos JM, Bussi C, Avalos MP, Cancela LM, Iribarren P.

Front Immunol. 2018 Apr 17;9:770. doi: 10.3389/fimmu.2018.00770. eCollection 2018.

13.

Permanent pacemaker implantation after cardiac surgery: rates, predictors and a novel risk score.

Wang TKM, Arroyo D, Martin A, McGeorge A, Gillham M.

N Z Med J. 2018 Apr 13;131(1473):88-91. No abstract available.

PMID:
29649203
14.

Impact of intravascular thrombosis on failure of radial arterial catheters in critically ill patients: a nested case-control study.

Fleury Y, Arroyo D, Couchepin C, Robert-Ebadi H, Righini M, Lobrinus JA, Ricou B, Delieuvin Schmitt N, Gayet-Ageron A.

Intensive Care Med. 2018 May;44(5):553-563. doi: 10.1007/s00134-018-5149-1. Epub 2018 Apr 2. Erratum in: Intensive Care Med. 2018 May 30;:.

PMID:
29610936
15.

Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper.

Abraham P, Arroyo DA, Giraud R, Bounameaux H, Bendjelid K.

Open Heart. 2018 Feb 26;5(1):e000735. doi: 10.1136/openhrt-2017-000735. eCollection 2018. Review.

16.

Hybridization Kinetics Explains CRISPR-Cas Off-Targeting Rules.

Klein M, Eslami-Mossallam B, Arroyo DG, Depken M.

Cell Rep. 2018 Feb 6;22(6):1413-1423. doi: 10.1016/j.celrep.2018.01.045.

17.

Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial.

Arroyo DA, Schukraft S, Kallinikou Z, Stauffer JC, Baeriswyl G, Goy JJ, Togni M, Cook S, Puricel S.

Open Heart. 2018 Jan 3;5(1):e000624. doi: 10.1136/openhrt-2017-000624. eCollection 2018.

18.

Type I IFNs Are Required to Promote Central Nervous System Immune Surveillance through the Recruitment of Inflammatory Monocytes upon Systemic Inflammation.

Peralta Ramos JM, Bussi C, Gaviglio EA, Arroyo DS, Baez NS, Rodriguez-Galan MC, Iribarren P.

Front Immunol. 2017 Dec 4;8:1666. doi: 10.3389/fimmu.2017.01666. eCollection 2017.

19.

Beyond the traditional lipid parameters in chronic kidney disease.

Bermúdez-López M, Betriu À, Valdivielso JM, Bretones Del Pino T, Arroyo D, Fernández E.

Nefrologia. 2018 Mar - Apr;38(2):109-113. doi: 10.1016/j.nefro.2017.09.008. Epub 2017 Nov 11. English, Spanish. No abstract available.

20.

Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound.

Valdivielso JM, Betriu A, Martinez-Alonso M, Arroyo D, Bermudez-Lopez M, Fernandez E; NEFRONA investigators.

PLoS One. 2017 Oct 18;12(10):e0186665. doi: 10.1371/journal.pone.0186665. eCollection 2017.

21.

Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia.

Rodríguez CM, Stanganelli C, Bussi C, Arroyo D, Sastre D, Heller V, Iribarren P, Slavutsky I.

Leuk Lymphoma. 2018 May;59(5):1239-1243. doi: 10.1080/10428194.2017.1370549. Epub 2017 Sep 3. No abstract available.

PMID:
28868956
22.

New perspectives on CKD-induced dyslipidemia.

Bermúdez-López M, Arroyo D, Betriu À, Masana L, Fernández E, Valdivielso JM.

Expert Opin Ther Targets. 2017 Oct;21(10):967-976. doi: 10.1080/14728222.2017.1369961. Epub 2017 Aug 28. Review.

PMID:
28829206
23.

Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial.

Arroyo D, Gendre G, Schukraft S, Kallinikou Z, Müller O, Baeriswyl G, Stauffer JC, Goy JJ, Togni M, Cook S, Puricel S.

Int J Cardiol. 2017 Sep 15;243:121-125. doi: 10.1016/j.ijcard.2017.05.053. Epub 2017 May 12.

PMID:
28576627
24.

Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.

Albillos A, Zamora J, Martínez J, Arroyo D, Ahmad I, De-la-Peña J, Garcia-Pagán JC, Lo GH, Sarin S, Sharma B, Abraldes JG, Bosch J, Garcia-Tsao G; Baveno Cooperation.

Hepatology. 2017 Oct;66(4):1219-1231. doi: 10.1002/hep.29267. Epub 2017 Aug 26.

25.

Autophagy down regulates pro-inflammatory mediators in BV2 microglial cells and rescues both LPS and alpha-synuclein induced neuronal cell death.

Bussi C, Peralta Ramos JM, Arroyo DS, Gaviglio EA, Gallea JI, Wang JM, Celej MS, Iribarren P.

Sci Rep. 2017 Mar 3;7:43153. doi: 10.1038/srep43153.

26.

Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study.

Sánchez E, Betriu À, Arroyo D, López C, Hernández M, Rius F, Fernández E, Lecube A.

PLoS One. 2017 Jan 31;12(1):e0170778. doi: 10.1371/journal.pone.0170778. eCollection 2017.

27.

Protein-bound toxins: added value in their removal with high convective volumes.

Abad S, Vega A, Quiroga B, Arroyo D, Panizo N, Reque JE, López-Gómez JM.

Nefrologia. 2016 Nov - Dec;36(6):637-642. doi: 10.1016/j.nefro.2016.05.013. Epub 2016 Aug 31. English, Spanish.

28.

EtCO₂ and Lactate: Correlation may be key to early sepsis detection.

Arroyo D.

JEMS. 2016 Sep;41(9):48-9. No abstract available.

PMID:
29182252
29.

Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study.

Abajo M, Betriu À, Arroyo D, Gracia M, Del Pino MD, Martínez I, Valdivielso JM, Fernández E; Investigators of the NEFRONA study.

Nephrol Dial Transplant. 2017 Nov 1;32(11):1882-1891. doi: 10.1093/ndt/gfw306.

PMID:
27566835
30.

Spatiotemporal Features of Retinal Waves Instruct the Wiring of the Visual Circuitry.

Arroyo DA, Feller MB.

Front Neural Circuits. 2016 Jul 26;10:54. doi: 10.3389/fncir.2016.00054. eCollection 2016. Review.

31.

Suspected Arterial Vasospasm in Femoro-Femoral Venoarterial Extracorporeal Life Support.

Arroyo D, Bendjelid K, Robert-Ebadi H, Rigamonti F, Siegenthaler N, Giraud R.

ASAIO J. 2017 May/Jun;63(3):e35-e38. doi: 10.1097/MAT.0000000000000423.

PMID:
27465096
32.

Retinal Waves Modulate an Intraretinal Circuit of Intrinsically Photosensitive Retinal Ganglion Cells.

Arroyo DA, Kirkby LA, Feller MB.

J Neurosci. 2016 Jun 29;36(26):6892-905. doi: 10.1523/JNEUROSCI.0572-16.2016.

33.

Bioresorbable vascular scaffolds-time to vanish?

Arroyo D, Cook S, Puricel S.

J Thorac Dis. 2016 Jun;8(6):E431-6. doi: 10.21037/jtd.2016.04.50.

34.

Descriptive analysis of the type and design of contact lenses fitted according to keratoconus severity and morphology.

Lunardi LH, Arroyo D, Andrade Sobrinho MV, Lipener C, Rosa JM.

Arq Bras Oftalmol. 2016 Apr;79(2):82-4. doi: 10.5935/0004-2749.20160025.

35.

Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.

Arroyo D, Betriu A, Valls J, Gorriz JL, Pallares V, Abajo M, Gracia M, Valdivielso JM, Fernandez E; Investigators from the NEFRONA study.

Nephrol Dial Transplant. 2017 Mar 1;32(3):513-520. doi: 10.1093/ndt/gfw039.

PMID:
27190385
36.

Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project.

Betriu À, Farràs C, Abajo M, Martinez-Alonso M, Arroyo D, Barbé F, Buti M, Lecube A, Portero M, Purroy F, Torres G, Valdivielso JM, Fernández E.

Nefrologia. 2016 Jul-Aug;36(4):389-96. doi: 10.1016/j.nefro.2016.02.008. Epub 2016 Apr 1. English, Spanish.

37.

Mechanisms of Late and Very Late Bioresorbable Vascular Scaffold Thrombosis: Is it Only About Flow?

Arroyo D, Cook S, Puricel S.

J Am Coll Cardiol. 2016 Mar 15;67(10):1259-1260. doi: 10.1016/j.jacc.2015.11.062. No abstract available.

38.

Heart rate never lies: interventional cardiologist and Braude's quote revised.

Cook S, Stauffer JC, Goy JJ, Graf D, Puricel S, Frobert A, Muller O, Togni M, Arroyo D.

Open Heart. 2016 Jan 11;3(1):e000373. doi: 10.1136/openhrt-2015-000373. eCollection 2016.

39.

Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trial.

Kallinikou Z, Arroyo D, Togni M, Lehman S, Corpataux N, Cook M, Müller O, Baeriswyl G, Stauffer JC, Goy JJ, Puricel SG, Cook S.

Swiss Med Wkly. 2016 Jan 14;146:w14274. doi: 10.4414/smw.2016.14274. eCollection 2016.

40.

Successful heart transplantation after prolonged cardiac arrest and extracorporeal life support in organ donor-a case report.

Arroyo D, Gasche Y, Banfi C, Stiasny B, Bendjelid K, Giraud R.

J Cardiothorac Surg. 2015 Dec 18;10:186. doi: 10.1186/s13019-015-0393-8.

41.

Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.

Gracia M, Betriu À, Martínez-Alonso M, Arroyo D, Abajo M, Fernández E, Valdivielso JM; NEFRONA Investigators.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):287-96. doi: 10.2215/CJN.01240215. Epub 2015 Dec 14.

42.

Impact of the Limitations in Fluid Overload Assessment by Bioimpedance Spectroscopy.

Arroyo D, Panizo N, Abad S, Vega A, Rincón A, de José AP, López-Gómez JM.

Perit Dial Int. 2015 Sep-Oct;35(5):604. doi: 10.3747/pdi.2015.00164. No abstract available.

43.

Comparison of endothelium-dependent and -independent vasomotor response after abluminal biodegradable polymer biolimus-eluting stent and persistent polymer everolimus-eluting stent implantation (COMPARE-IT).

Puricel S, Kallinikou Z, Espinola J, Arroyo D, Goy JJ, Stauffer JC, Baeriswyl G, Smits PC, Cook S, Togni M.

Int J Cardiol. 2016 Jan 1;202:525-31. doi: 10.1016/j.ijcard.2015.09.085. Epub 2015 Sep 26.

PMID:
26440470
44.

Coronary healing after stenting: wounds, faith, and the quest for the perfect stent.

Puricel S, Cook S, Arroyo D.

Eur Heart J Cardiovasc Imaging. 2016 Jan;17(1):12-4. doi: 10.1093/ehjci/jev226. Epub 2015 Sep 15. No abstract available.

PMID:
26377906
45.

Acute kidney injury secondary to very severe hypercalcaemic crisis caused by primary hyperparathyroidism.

Chacón A, Vilar A, Arroyo D, Sarró F, Craver L, Ros S, López C, Castillo A, Matías-Guiu X, Fernández-Giráldez E.

Nefrologia. 2015;35(2):224-6. doi: 10.1016/j.nefro.2015.05.024. Epub 2015 Jun 23. English, Spanish. No abstract available.

46.

Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes.

Llibre JM, Rivero A, Rojas JF, Garcia Del Toro M, Herrero C, Arroyo D, Pineda JA, Pasquau J, Masiá M, Crespo M, Blanco JR, Moreno S.

Antiviral Res. 2015 Aug;120:79-84. doi: 10.1016/j.antiviral.2015.05.001. Epub 2015 May 12.

PMID:
25977241
47.

Three cases with L1 syndrome and two novel mutations in the L1CAM gene.

Marín R, Ley-Martos M, Gutiérrez G, Rodríguez-Sánchez F, Arroyo D, Mora-López F.

Eur J Pediatr. 2015 Nov;174(11):1541-4. doi: 10.1007/s00431-015-2560-2. Epub 2015 May 7.

PMID:
25948108
48.

Present and future in the treatment of diabetic kidney disease.

Quiroga B, Arroyo D, de Arriba G.

J Diabetes Res. 2015;2015:801348. doi: 10.1155/2015/801348. Epub 2015 Apr 7. Review.

49.

Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.

Puricel S, Arroyo D, Corpataux N, Baeriswyl G, Lehmann S, Kallinikou Z, Muller O, Allard L, Stauffer JC, Togni M, Goy JJ, Cook S.

J Am Coll Cardiol. 2015 Mar 3;65(8):791-801. doi: 10.1016/j.jacc.2014.12.017.

50.

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study.

Elías MJ, Arroyo D, Diaz A, Herrero C, Martinez-Dueñas L, Moreno A, Hernández-Quero J, Podzamcer D, Gomez-Ayerbe C, Casado JL, Zamora J, Rivero A, Moreno S, Llibre JM.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19800. doi: 10.7448/IAS.17.4.19800. eCollection 2014.

Supplemental Content

Loading ...
Support Center